Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer Stage II Randomized Controlled Clinical Studies
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 02 May 2016
At a glance
- Drugs Apatinib (Primary) ; Docetaxel
- Indications Gastric cancer
- Focus Therapeutic Use
- 02 May 2016 Last checked against ClinicalTrials.gov record.
- 26 Apr 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 26 Apr 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Apr 2017.